Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SANA Sana Biotechnology Inc
- Stocks
- Healthcare
- NASDAQ: SANA
Price (delayed)
$1.745
Market cap
$393.59M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.88
Enterprise value
$384.58M
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and
Highlights
The EPS is up by 42% year-on-year and by 24% since the previous quarter
The net income is up by 32% year-on-year and by 22% since the previous quarter
SANA's quick ratio is down by 45% YoY and by 4.7% from the previous quarter
The equity has contracted by 44% YoY and by 17% from the previous quarter
Key stats
What are the main financial stats of SANA
Market
Valuations
Earnings
Shares outstanding
225.56M
Market cap
$393.59M
Enterprise value
$384.58M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.88
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$212.63M
Net income
-$208.67M
EBIT
-$208.67M
EBITDA
-$182.8M
Free cash flow
-$223.65M
Per share
Balance sheet
Liquidity
EPS
-$0.88
EPS diluted
-$0.88
Free cash flow per share
-$0.94
Book value per share
$0.93
Revenue per share
$0
TBVPS
$1.03
Total assets
$445.47M
Total liabilities
$236.39M
Debt
$91.31M
Equity
$209.08M
Working capital
$79.58M
Debt to equity
0.44
Current ratio
3.4
Quick ratio
3.28
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-39.3%
Return on equity
-76.5%
Return on invested capital
-81.2%
Return on capital employed
-50.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SANA stock price
How has the Sana Biotechnology stock price performed over time
Intraday
2.05%
1 week
-4.12%
1 month
10.44%
1 year
-79.59%
YTD
7.06%
QTD
3.87%
Financial performance
How have Sana Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$212.63M
Net income
-$208.67M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 34% YoY and by 22% from the previous quarter
The net income is up by 32% year-on-year and by 22% since the previous quarter
Price vs fundamentals
How does SANA's price correlate with its fundamentals
Growth
What is Sana Biotechnology's growth rate over time
Valuation
What is Sana Biotechnology stock price valuation
P/E
N/A
P/B
1.88
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 42% year-on-year and by 24% since the previous quarter
The equity has contracted by 44% YoY and by 17% from the previous quarter
SANA's P/B is 39% below its 5-year quarterly average of 3.1 and 25% below its last 4 quarters average of 2.5
Efficiency
How efficient is Sana Biotechnology business performance
The company's return on invested capital rose by 18% YoY and by 10% QoQ
Sana Biotechnology's ROA has increased by 18% YoY and by 13% from the previous quarter
The return on equity has grown by 14% year-on-year and by 10% since the previous quarter
Dividends
What is SANA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SANA.
Financial health
How did Sana Biotechnology financials performed over time
The company's total assets is 88% higher than its total liabilities
SANA's quick ratio is down by 45% YoY and by 4.7% from the previous quarter
The current ratio is down by 44% YoY and by 4% from the previous quarter
SANA's debt is 56% smaller than its equity
The debt to equity has surged by 57% year-on-year and by 16% since the previous quarter
The equity has contracted by 44% YoY and by 17% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.